Vendome Acquisition Corporation I
VNME · NASDAQ
About VNME
- Employees
- 0
- Headquarters
- Park City, Utah
- Listed
- Jun 27, 2025
- Sector
- N/A
- Industry
- N/A
VNME key statistics
- Market cap
- 257.75M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 45.92K
- Volume
- 965
- Open price
- $10.34
- High today
- $10.34
- Low today
- $10.34
- 52 Week high
- $10.34
- 52 Week low
- $10.00
Vendome Acquisition Corporation I (VNME) at a glance
As of Oct 29, 2026, Vendome Acquisition Corporation I (VNME) shares are priced at $10.34, giving the company a market cap of 257.75M and a price-to-earnings ratio of 0.00.
Volume so far is 965 shares, below the average of 45.92K shares a day.
Over the past year Vendome Acquisition Corporation I has ranged from $10.00 to $10.34, and now sits 100% of the way up that range.
Most active stocks
Highest trading volume today
- GTVHGolden Triangle Ventures$0.0001−50.00%
- BURUNuburu$0.3717+115.98%
- RDARRaadr$0.0002+0.00%
- WFFWF Holding$1.50+13.21%
- INLFINLIF$0.265+47.22%
- EARIEntertainment Arts Research$0.0002+0.00%
- ADTADT$9.87+33.20%
- AITXArtificial Intelligence Technology Solutions$0.0008+77.78%
- GOOGLAlphabet$283.82−12.64%
- NVDGraniteShares ETF Trust$4.09+2.00%
- INTCIntel$92.07−3.62%
- TIPSTianrong Internet Products & Services$0.0015+7.14%
Newly listed
Companies that went public in the past six weeks
- SCQCUSPACCircle Acquisition$9.98+0.10%
- LYCALycia Therapeutics$27.73+10.70%
- DAVIDAVION HEALTHCARE$2.69−18.24%
- TCXBTCGX Acquisition Corp. II$10.21−0.61%
- CTYCITY THERAPEUTICS$22.14+2.26%
- IAMIambic Therapeutics$14.28−3.38%
- AMROAmaero$5.78−1.37%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.21−0.20%
- TRXBTRex Bio$13.52−6.31%
- RTSNRetension Pharmaceuticals$11.83−9.63%
- PAXGUPine Tree Acquisition$10.02−0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.